CSI Market
Sign In | Register

Zomedica (ZOMDF) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access ZOMDF Annual Cash Flow →
The cash flow figures below highlight longer-term patterns in how Zomedica manages cash inflows and outflows over time.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Mar 31 2026)
3 Months 		(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Operating Activities
Income-4.53
Depreciation & amortization0.52
Amortization of Other Assets1.37
Extraordinary Item, Gain (Loss), Insurance Assets, Accretion Expense0.00
Asset Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories-0.35
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Property Plant Equipment0.02
Share-based Compensation0.64
Income (Loss) from Equity Method Investments0.03
Financial Instruments and Foreign Currency Transaction0.00
Operating Lease Right Of Use Asset Amortization Expense-
Operating Lease Impairment Loss-
Gain Loss On Operating Lease Right Of Use Assets-
Gains Losses On Sales Of Assets-
Non Cash Portion Of Rent Expense-
Non Cash Portion Of Rent Benefit Expense-
Lease Expense Benefit Non Cash-0.01
Increase Decrease In Contract With Customer Liability0.03
Income taxes-0.04
Losses/ -gains on Investments net0.00
Accounts Receivable-1.32
Increase (Decrease) in Accounts Payable0.39
Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities-1.80
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense-0.04
Other Working Capital-0.05
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities-0.11
Discontinued operations0.00
Net Cash flow from Operating Activities-5.26
Investing Activities
Capital Expenditures-0.51
Sale of Capital Items0.00
Payments for (Proceeds from) Short-term Investments, Total6.14
Short-term Investments Acq.0.00
Real Estate Investments0.00
Proceeds From Refund Of Prepaid Rent-
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Payments to Acquire Equity Method Investments0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities5.62
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net-0.02
Proceeds From Amalgamation-
Proceeds From Pending Warrant Exercises-
Proceeds For Government Loan-
Proceeds From Common Stock Subscribed-
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations-
Transfer Of Inventory Into Property And Equipment0.02
Cash Received From Stock Option Exercises-
Cash Received From Shares To Be Issued-
Payments Of Stock Issuance Cost-
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.00
Effect of exchange rate on cash flow-0.01
Discontinued operations0.00
Free Cash Flow-5.77
Total Cash Flow0.37
4 historic quarters locked

Sign in to unlock the full Zomedica cash flow history.

Sign In Create Free Account

About Zomedica Corp Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.
  • Accession: 0001104659-26-091075

Figures are derived from filed reports and may be restated. Historical data is subject to revision.